In addition to the markers mentioned above, expression of CD45, although frequently difficult to assess, EMA, J-chain and myocyte enhancer factor 2B (MEF2B) are useful in differentiating NLPHL from CHL [64]. The gene discussed is MEF2B; the disease is classic Hodgkin lymphoma.